Last reviewed · How we verify

PENICILLIN G BENZATHINE — Competitive Intelligence Brief

PENICILLIN G BENZATHINE (PENICILLIN G BENZATHINE) competitive landscape: 3 comparators, recent regulatory actions, upcoming PDUFA, patent timeline.

marketed cell-wall peptidoglycan Small molecule Live · refreshed every 30 min

Target snapshot

PENICILLIN G BENZATHINE (PENICILLIN G BENZATHINE). Penicillin G kills bacteria by inhibiting cell-wall peptidoglycan synthesis, making the cell wall unstable.

Comparator set (3 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
PENICILLIN G BENZATHINE TARGET PENICILLIN G BENZATHINE marketed cell-wall peptidoglycan 1952-01-01
Bicillin C-R Penicillin G Benzathine Pfizer marketed Beta-lactam antibiotic Cell-wall peptidoglycan biosynthesis 1952-01-01
Bicillin C-R Penicillin G Benzathine Pfizer marketed Beta-lactam antibiotic Cell-wall peptidoglycan biosynthesis 1952-01-01
Bicillin C-R Penicillin G Benzathine Pfizer Inc. marketed Beta-lactam antibiotic Cell-wall peptidoglycan biosynthesis

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape

No sponsor landscape data.

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). PENICILLIN G BENZATHINE — Competitive Intelligence Brief. https://druglandscape.com/ci/penicillin-g-benzathine. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators: